BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4692869)

  • 1. Radiotherapy of experimental lung tumors in the presence and absence of a radioprotective drug, S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721).
    Yuhas JM
    J Natl Cancer Inst; 1973 Jan; 50(1):69-78. PubMed ID: 4692869
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement of lung tumor radiotherapy through differential chemoprotection of normal and tumor tissue.
    Yuhas JM
    J Natl Cancer Inst; 1972 Apr; 48(4):1255-7. PubMed ID: 5023684
    [No Abstract]   [Full Text] [Related]  

  • 3. Radioprotective and toxic effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721) on the development of immunocompetent cells.
    Yuhas JM
    Cell Immunol; 1972 Jul; 4(3):256-63. PubMed ID: 5064475
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR 2721) on intestinal crypt survival. II. Fission neutrons.
    Sigdestad CP; Connor AM; Scott RM
    Radiat Res; 1976 Mar; 65(3):430-9. PubMed ID: 1265205
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy.
    Yuhas JM; Yurconic M; Kligerman MM; West G; Peterson DF
    Radiat Res; 1977 May; 70(2):433-43. PubMed ID: 193145
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of WR-2721 in radiotherapy and/or chemotherapy.
    Yuhas JM; Spellman JM; Culo F
    Cancer Clin Trials; 1980; 3(3):211-6. PubMed ID: 6254681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioprotection of mouse testis by S-2-(3-aminopropylamino)ethylphosphorothioic acid.
    Bhartiya J; Bhartiya HC
    Radiobiol Radiother (Berl); 1985; 26(3):389-93. PubMed ID: 2997832
    [No Abstract]   [Full Text] [Related]  

  • 8. Protection of cultured mammalian cells by S-2-(3-aminopropylamino)ethylphosphorothioic acid(WR-2721).
    Antoku S
    Int J Radiat Oncol Biol Phys; 1983 Oct; 9(10):1481-5. PubMed ID: 6313559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor rejection in experimental animals treated with radioprotective thiols.
    Apffel CA; Walker JE; Issarescu S
    Cancer Res; 1975 Feb; 35(2):429-37. PubMed ID: 234035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the radioprotective drugs MEA, DMSO, and WR-2721 on tumor control and skin tolerance in the rat.
    Moulder JE; Lo PS; Fischer JJ
    Cancer Treat Rep; 1977 Aug; 61(5):825-33. PubMed ID: 196752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tumor type, size, and endpoint on tumor radioprotection by WR-2721.
    Milas L; Hunter N; Ito H; Peters LJ
    Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):41-8. PubMed ID: 6321411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice.
    Milas L; Hunter N; Reid BO; Thames HD
    Cancer Res; 1982 May; 42(5):1888-97. PubMed ID: 6279288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation protection of rat parenchymal hepatocytes with S-2-(3-aminopropylamino)ethylphosphorothioic acid.
    Jirtle RL; Pierce LJ; Crocker IR; Strom SC
    Radiother Oncol; 1985 Nov; 4(3):231-7. PubMed ID: 3001838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of mouse lung by WR-2721 after fractionated doses of irradiation.
    Travis EL; De Luca AM
    Int J Radiat Oncol Biol Phys; 1985 Mar; 11(3):521-6. PubMed ID: 2982773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR-2721: LD50 studies and 35S-WR-2721 biodistribution.
    Rasey JS; Nelson NJ; Mahler P; Anderson K; Krohn KA; Menard T
    Radiat Res; 1984 Mar; 97(3):598-607. PubMed ID: 6328565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological factors affecting the radioprotective efficiency of S-2-[3-aminopropylamino]ethylphosphorothioic acid (WR-2721): LD 50(7) doses.
    Yuhas JM
    Radiat Res; 1971 Aug; 47(2):526-9. PubMed ID: 5561940
    [No Abstract]   [Full Text] [Related]  

  • 17. Exposure-response curve for radiation-induced lung tumors in the mouse.
    Yuhas JM; Walker AE
    Radiat Res; 1973 May; 54(2):261-73. PubMed ID: 4703887
    [No Abstract]   [Full Text] [Related]  

  • 18. Opposite effects of WR-2721 and WR-1065 on radiation-induced hypothermia: possible correlation with oxygen uptake.
    Kandasamy SB; Kumar KS; Hunt WA; Weiss JF
    Radiat Res; 1988 May; 114(2):240-7. PubMed ID: 2836882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of WR-2721 against radiation-induced injury of murine gut, testis, lung, and lung tumor nodules.
    Milas L; Hunter N; Reid BO
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):535-8. PubMed ID: 6286549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against local irradiation injury to the skin by locally and systemically applied drugs.
    Lowy RO; Baker DG
    Radiology; 1972 Nov; 105(2):425-8. PubMed ID: 5079671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.